HS-20094
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
Regeneron · Phase 2 · Active, not recruiting · Enrollment 120
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| General Cohort | n/r | n/r | n/r | n/r | n/r |
| Subgroup Cohort | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.